These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2864029)

  • 21. The Nithsdale Schizophrenia survey: II. Abnormal movements.
    McCreadie RG; Barron ET; Winslow GS
    Br J Psychiatry; 1982 Jun; 140():587-90. PubMed ID: 6125227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Never treated schizophrenic patients have no abnormal movements such as tardive dyskinesia].
    Chorfi M; Moussaoui D
    Encephale; 1985; 11(6):263-5. PubMed ID: 2869939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tardive dyskinesia and type II schizophrenia.
    Davis EJ; Borde M; Sharma LN
    Br J Psychiatry; 1992 Feb; 160():253-6. PubMed ID: 1347240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
    Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
    Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tardive dyskinesia and deficit schizophrenia.
    Telfer S; Shivashankar S; Krishnadas R; McCreadie RG; Kirkpatrick B
    Acta Psychiatr Scand; 2011 Nov; 124(5):357-62. PubMed ID: 21838740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.
    Arango C; Adami H; Sherr JD; Thaker GK; Carpenter WT
    Am J Psychiatry; 1999 Jul; 156(7):1097-9. PubMed ID: 10401460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obstetric complications, the putative familial-sporadic distinction, and tardive dyskinesia in schizophrenia.
    O'Callaghan E; Larkin C; Kinsella A; Waddington JL
    Br J Psychiatry; 1990 Oct; 157():578-84. PubMed ID: 1983389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J
    J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia.
    McEvoy J; Gandhi SK; Rizio AA; Maher S; Kosinski M; Bjorner JB; Carroll B
    Qual Life Res; 2019 Dec; 28(12):3303-3312. PubMed ID: 31435866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.
    de Jesus Mari J; Lima MS; Costa AN; Alexandrino N; Rodrigues-Filho S; de Oliveira IR; Tollefson GD
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):356-61. PubMed ID: 15538607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical correlates of distinct topographies of tardive dyskinesia in schizophrenia.
    Waddington JL; Youssef HA; Kinsella A
    Am J Psychiatry; 1993 Nov; 150(11):1757-8. PubMed ID: 8105709
    [No Abstract]   [Full Text] [Related]  

  • 35. The clinical correlates of neurological soft signs in chronic schizophrenia.
    King DJ; Wilson A; Cooper SJ; Waddington JL
    Br J Psychiatry; 1991 Jun; 158():770-5. PubMed ID: 1678661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
    Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML
    Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
    Tan YL; Zhou DF; Zhang XY
    Schizophr Res; 2005 May; 74(2-3):263-70. PubMed ID: 15722005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in tardive dyskinesia: a critical review of the literature.
    Yassa R; Jeste DV
    Schizophr Bull; 1992; 18(4):701-15. PubMed ID: 1359633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pro- and antioxidant processes in schizophrenics with tardive dyskinesia].
    Gałecki P; Pietras T; Florkowki A
    Psychiatr Pol; 2005; 39(6):1131-41. PubMed ID: 16526180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tardive dyskinesia--diagnostic issues, subsyndromes, and concurrent movement disorders: a study of state hospital inpatients referred to a movement disorder consultation service.
    Lauterbach EC; Carter WG; Rathke KM; Thomas BH; Shillcutt SD; Vogel RL; Moore NC; Mimbs JW; Nelson WH
    Schizophr Bull; 2001; 27(4):601-13. PubMed ID: 11824487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.